Sino Biopharmaceutical Ltd - Net Income Including Non Controlling Interests

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "Net-Income-Including-Non-Controlling-Interests" stands at 6.90 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 09/30/2022.

Sino Biopharmaceutical Ltd's second quarter result of 2.49 Billion HKD for the item "Net Income Including Non Controlling Interests" represents no change compared to it's first quarter result.

Also, Sino Biopharmaceutical Ltd's second quarter result of 2.49 Billion HKD for the item "Net Income Including Non Controlling Interests" represents an increase of 124.47 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sino Biopharmaceutical Ltd's second quarter result of 6.90 Billion HKD for the item "Net Income Including Non Controlling Interests" represents an increase of 25.07 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 60.15 percent compared to the value the year prior.
The 1 year change in percent is 60.15.
The 3 year change in percent is -16.15.
The 5 year change in percent is 52.31.
The 10 year change in percent is 223.59.

The Serie's long term average value is 4.42 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is 56.01 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 06/30/2025, is +927.38%.
The Serie's change in percent from it's maximum value, on 12/31/2021, to it's latest available value, on 06/30/2025, is -52.51%.